These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 23295955

  • 1. High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion.
    Lehtinen L, Ketola K, Mäkelä R, Mpindi JP, Viitala M, Kallioniemi O, Iljin K.
    Oncotarget; 2013 Jan; 4(1):48-63. PubMed ID: 23295955
    [Abstract] [Full Text] [Related]

  • 2. MTHFD2 Overexpression Predicts Poor Prognosis in Renal Cell Carcinoma and is Associated with Cell Proliferation and Vimentin-Modulated Migration and Invasion.
    Lin H, Huang B, Wang H, Liu X, Hong Y, Qiu S, Zheng J.
    Cell Physiol Biochem; 2018 Jan; 51(2):991-1000. PubMed ID: 30466107
    [Abstract] [Full Text] [Related]

  • 3. Methylenetetrahydrofolate dehydrogenase 2 overexpression is associated with tumor aggressiveness and poor prognosis in hepatocellular carcinoma.
    Liu X, Huang Y, Jiang C, Ou H, Guo B, Liao H, Li X, Yang D.
    Dig Liver Dis; 2016 Aug; 48(8):953-60. PubMed ID: 27257051
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling.
    Cui X, Su H, Yang J, Wu X, Huo K, Jing X, Zhang S.
    J Ovarian Res; 2022 Feb 08; 15(1):23. PubMed ID: 35135596
    [Abstract] [Full Text] [Related]

  • 5. MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK-3β/β-catenin signalling.
    Shi Y, Xu Y, Yao J, Yan C, Su H, Zhang X, Chen E, Ying K.
    J Cell Mol Med; 2021 Jul 08; 25(14):7013-7027. PubMed ID: 34121323
    [Abstract] [Full Text] [Related]

  • 6. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer.
    Nilsson R, Jain M, Madhusudhan N, Sheppard NG, Strittmatter L, Kampf C, Huang J, Asplund A, Mootha VK.
    Nat Commun; 2014 Jul 08; 5():3128. PubMed ID: 24451681
    [Abstract] [Full Text] [Related]

  • 7. MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway.
    Li Q, Yang F, Shi X, Bian S, Shen F, Wu Y, Zhu C, Fu F, Wang J, Zhou J, Chen Y.
    FEBS Open Bio; 2021 Oct 08; 11(10):2845-2857. PubMed ID: 34231329
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes.
    Yu C, Yang L, Cai M, Zhou F, Xiao S, Li Y, Wan T, Cheng D, Wang L, Zhao C, Huang X.
    J Cell Mol Med; 2020 Jan 08; 24(2):1568-1577. PubMed ID: 31778025
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-33a-5p suppresses colorectal cancer cell growth by inhibiting MTHFD2.
    Yan Y, Zhang D, Lei T, Zhao C, Han J, Cui J, Wang Y.
    Clin Exp Pharmacol Physiol; 2019 Oct 08; 46(10):928-936. PubMed ID: 31209892
    [Abstract] [Full Text] [Related]

  • 10. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
    Huanna T, Tao Z, Xiangfei W, Longfei A, Yuanyuan X, Jianhua W, Cuifang Z, Manjing J, Wenjing C, Shaochuan Q, Feifei X, Naikang L, Jinchao Z, Chen W.
    Mol Carcinog; 2015 Oct 08; 54(10):1159-71. PubMed ID: 24962947
    [Abstract] [Full Text] [Related]

  • 11. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells.
    Sehrawat A, Singh SV.
    Cancer Prev Res (Phila); 2011 Jul 08; 4(7):1107-17. PubMed ID: 21464039
    [Abstract] [Full Text] [Related]

  • 12. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
    Han M, Liu M, Wang Y, Mo Z, Bi X, Liu Z, Fan Y, Chen X, Wu C.
    Mol Cell Biochem; 2012 Apr 08; 363(1-2):427-36. PubMed ID: 22187223
    [Abstract] [Full Text] [Related]

  • 13. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
    Uchino M, Kojima H, Wada K, Imada M, Onoda F, Satofuka H, Utsugi T, Murakami Y.
    BMC Cancer; 2010 Aug 10; 10():414. PubMed ID: 20696077
    [Abstract] [Full Text] [Related]

  • 14. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
    Martowicz A, Spizzo G, Gastl G, Untergasser G.
    BMC Cancer; 2012 Oct 30; 12():501. PubMed ID: 23110550
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
    Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC, Chao JI, Liu HF, Ding SL, Shen CY.
    Breast Cancer Res Treat; 2012 Aug 30; 134(3):1081-93. PubMed ID: 22476851
    [Abstract] [Full Text] [Related]

  • 16. Interference with MTHFD2 induces ferroptosis in ovarian cancer cells through ERK signaling to suppress tumor malignant progression.
    Mo X, Liu Q, Liang K, Song Y.
    J Bioenerg Biomembr; 2024 Jun 30; 56(3):333-345. PubMed ID: 38488992
    [Abstract] [Full Text] [Related]

  • 17. [The siRNA-mediated silencing of Bmi-1 promotes apoptosis and inhibits invasion of MCF-7 breast cancer cells].
    Deng X, Wu X, Weng H, Song F.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug 30; 32(8):1036-40. PubMed ID: 27412932
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion.
    Wang SH, Zhang MD, Wu XC, Weng MZ, Zhou D, Quan ZW.
    Tumour Biol; 2016 Sep 30; 37(9):12867-12875. PubMed ID: 27449039
    [Abstract] [Full Text] [Related]

  • 19. Activation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cells.
    Wang PC, Weng CC, Hou YS, Jian SF, Fang KT, Hou MF, Cheng KH.
    Int J Mol Sci; 2014 Feb 27; 15(3):3560-79. PubMed ID: 24583847
    [Abstract] [Full Text] [Related]

  • 20. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis.
    Shriver M, Stroka KM, Vitolo MI, Martin S, Huso DL, Konstantopoulos K, Kontrogianni-Konstantopoulos A.
    Oncogene; 2015 Aug 06; 34(32):4248-59. PubMed ID: 25381817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.